Cargando…
Transformer neural network for protein-specific de novo drug generation as a machine translation problem
Drug discovery for a protein target is a very laborious, long and costly process. Machine learning approaches and, in particular, deep generative networks can substantially reduce development time and costs. However, the majority of methods imply prior knowledge of protein binders, their physicochem...
Autor principal: | Grechishnikova, Daria |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7801439/ https://www.ncbi.nlm.nih.gov/pubmed/33432013 http://dx.doi.org/10.1038/s41598-020-79682-4 |
Ejemplares similares
-
AlphaDrug: protein target specific de novo molecular generation
por: Qian, Hao, et al.
Publicado: (2022) -
Generative Recurrent Networks for De Novo Drug Design
por: Gupta, Anvita, et al.
Publicado: (2017) -
Conserved 3′ UTR stem-loop structure in L1 and Alu transposons in human genome: possible role in retrotransposition
por: Grechishnikova, Daria, et al.
Publicado: (2016) -
Prediction of drug metabolites using neural machine translation
por: Litsa, Eleni E., et al.
Publicado: (2020) -
Memory augmented recurrent neural networks for de-novo drug design
por: Suresh, Naveen, et al.
Publicado: (2022)